Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
UNCY
UNCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
UNCY News
Kuehn Law Investigates Unicycive Executives for Fiduciary Breaches
Apr 09 2026
Newsfilter
Kuehn Law Investigates Unicycive Executives for Fiduciary Breaches
Apr 09 2026
PRnewswire
Unicycive Therapeutics Reports FY Loss and Cash Position
Mar 30 2026
seekingalpha
ASP Isotopes Class Action Survives Dismissal Motion
Mar 18 2026
Globenewswire
ASP Isotopes Class Action Survives Dismissal Motion
Mar 16 2026
Globenewswire
Unicycive's Drug Application Accepted by FDA with Target Date Set
Jan 29 2026
Newsfilter
Unicycive's Kidney Disease Therapy NDA Accepted by FDA
Jan 29 2026
seekingalpha
Unicycive's Drug Application Accepted by FDA
Jan 29 2026
Newsfilter
Unicycive Resubmits NDA for OLC to Treat Hyperphosphatemia in CKD Patients
Dec 29 2025
NASDAQ.COM
Unicycive Resubmits OLC NDA to FDA, Cash Runway Until 2027
Dec 29 2025
Globenewswire
Unicycive Resubmits OLC NDA to FDA, Cash Runway Until 2027
Dec 29 2025
Newsfilter
Quantum Corp Faces Investigation Over Financial Misstatements
Dec 18 2025
Globenewswire
Five Below (FIVE) Class Action Survives Dismissal Motion Amid Securities Fraud Allegations
Dec 03 2025
Globenewswire
Cytokinetics Faces Shareholder Investigation Over Alleged Misstatements
Dec 02 2025
Globenewswire
Post-Market Highlights: Jasper, NRx, Unicycive, Spruce, Evaxion, Solana, and Protara See Gains After Trading Hours
Dec 02 2025
NASDAQ.COM
Crucial Update for Long-Term Shareholders of Avantor, Inc. (NYSE: AVTR), Five Below, Inc. (NASDAQ: FIVE), Maison Solutions Inc. (NASDAQ: MSS), and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Looking into Claims for You
Nov 14 2025
Globenewswire
Show More News
